greeksoup/ stock research
Stock research / United States / FF / Q2 FY2026 / Earnings call

FutureFuel Corp.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 10 August 2026: press release. Guidance figures: 2 new, 1 kept. The quarter’s numbers.

Key takeaways

  • Revenue more than doubled year over year: Revenue rose on higher throughputs, an improved revenue mix and higher average pricing in both the Chemicals and Biofuels segments. Source
  • Net income positive after prior-year loss: GAAP net income was $11.4 million, or $0.25 per diluted share, against a prior-year net loss of $14.2 million. Adjusted EBITDA was $11.8 million, compared with negative $11.4 million a year earlier. Source
  • Derivative timing lifted gross profit: Gross profit of $15.0 million included $9.1 million from selling physical inventory above hedged prices, offsetting first-quarter realized derivative losses. Unrealized derivative gains of $3.2 million added further. Source
  • Chemicals revenue grew on energy volumes: Chemicals revenue rose to $25.8 million, with volume and product mix up 49% and average prices up 6%. Custom chemicals grew 30% on energy volumes, and performance chemicals rose 209% on a new customer. Source
  • Biofuels revenue rose on 45Z clarity: Biofuels revenue rose 178% to $52.9 million, driven by regulatory clarity on the Clean Fuel Production Credit and record-high renewable volume obligation levels. Production volume also rose from the first quarter. Source
  • Biofuels gross profit positive; base differs: Biofuels gross profit was $10.1 million, against a prior-year loss. The segment table shows the prior-year loss as $10.4 million, while the narrative gives $13.5 million. Source
  • Feedstock costs remain elevated: Input costs for soybean oil and other biofuel raw materials remain elevated and have partly offset favorable finished-product pricing, with a near-term effect on gross profit per gallon. Source
  • Operating cash flow rose year over year: Operating cash flow was $18.8 million, against $5.2 million a year earlier. Management said this included customer funding for a custom chemical contract. Source
  • Cash balance rose in the quarter: Cash rose from $22.4 million at March 31 to $34.4 million at June 30, with the $35 million revolver undrawn. The narrative text gives $34.3 million; the balance sheet shows $34.4 million. Source

“The second quarter marked a return to profitable growth for FutureFuel, a performance driven by strengthening end-market demand, improved production economics, continued cost discipline, and enhanced optimization of our Batesville plant,”

Roeland Polet, Chairman and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Biofuels plant utilization Sourcesecond half of 2026increase from 56% in the second quarterNew
Section 45Z credit monetization proceeds Sourcesecond half of 2026$22 million gross proceedsNew
Customer investment in Batesville capacity Source2026 and 2027$25 million in 2026; up to $17 million in 2027Kept

What changed from last quarter

  • Guidance kept: Full-year 2026 positive Adjusted EBITDA guidance was restated. The wording of the excluded derivative timing items changed from physical movements to changes in physical commodity prices. Source
  • New guidance: Third-quarter biodiesel production is now guided to exceed second-quarter levels. Source
  • New guidance: Biofuels plant utilization is now quantified as an increase from 56% in the second half of 2026. Source
  • New: A four-year agreement was secured with a third party to monetize Section 45Z and small producer tax credits. Source

Second quarter results

  • Revenue more than doubled year over year: Revenue rose on higher throughputs, an improved revenue mix and higher average pricing in both the Chemicals and Biofuels segments. Source
  • Net income positive after prior-year loss: GAAP net income was $11.4 million, or $0.25 per diluted share, against a prior-year net loss of $14.2 million. Adjusted EBITDA was $11.8 million, compared with negative $11.4 million a year earlier. Source
  • Derivative timing lifted gross profit: Gross profit of $15.0 million included $9.1 million from selling physical inventory above hedged prices, offsetting first-quarter realized derivative losses. Unrealized derivative gains of $3.2 million added further. Source

Chemicals segment

  • Chemicals revenue grew on energy volumes: Chemicals revenue rose to $25.8 million, with volume and product mix up 49% and average prices up 6%. Custom chemicals grew 30% on energy volumes, and performance chemicals rose 209% on a new customer. Source
  • Chemicals gross profit and prior-year base: Chemicals gross profit was $5.0 million. The prior-year figure reads $3.8 million in the segment narrative, $1.1 million in the CEO commentary and $1.7 million in the segment table. Source
  • Chemicals market conditions improved: Management said Chemicals market conditions improved through higher pricing and a growing project pipeline, and expects operating leverage as production scales from current levels. Source

“Second quarter Adjusted EBITDA increased to $11.8 million, an increase of more than $23 million versus the prior year, which supported improved free cash flow conversion in the period.”

Rose Sparks, Chief Financial Officer

Biofuels segment

  • Biofuels revenue rose on 45Z clarity: Biofuels revenue rose 178% to $52.9 million, driven by regulatory clarity on the Clean Fuel Production Credit and record-high renewable volume obligation levels. Production volume also rose from the first quarter. Source
  • Biofuels gross profit positive; base differs: Biofuels gross profit was $10.1 million, against a prior-year loss. The segment table shows the prior-year loss as $10.4 million, while the narrative gives $13.5 million. Source
  • Biofuels pricing and volumes improved: Management attributed the Biofuels gross profit improvement to higher sales volumes and stronger pricing realization. Source

Costs and input prices

  • Feedstock costs remain elevated: Input costs for soybean oil and other biofuel raw materials remain elevated and have partly offset favorable finished-product pricing, with a near-term effect on gross profit per gallon. Source
  • Both segments positive gross profit per unit: Management said both segments generated positive gross profit per unit sold, and cited improved plant reliability, higher throughputs and better production economics. Source
  • Chemicals gained from fixed-cost absorption: Chemicals margin also gained from fixed-price absorption linked to higher biofuel volumes, along with new product revenue that began in the fourth quarter of 2025. Source

“While our second quarter results include a timing benefit related to ongoing biofuels hedging activity, our core business performed well in the period,”

Roeland Polet, Chairman and Chief Executive Officer

Demand and utilization

  • Demand conditions said to persist: Management said demand conditions remain across both the chemicals and biofuels segments, and it described demand as continuing into the second half. Source
  • Utilization rose with new program wins: Utilization rose even as available capacity grew, which management linked to new program wins and growth from energy-related customers. Source
  • Biodiesel output expected to rise: Management expects third-quarter biodiesel production to exceed second-quarter levels, and expects Biofuels plant utilization to rise in the second half. Source

Cash, capital spending and returns

  • Operating cash flow rose year over year: Operating cash flow was $18.8 million, against $5.2 million a year earlier. Management said this included customer funding for a custom chemical contract. Source
  • Cash balance rose in the quarter: Cash rose from $22.4 million at March 31 to $34.4 million at June 30, with the $35 million revolver undrawn. The narrative text gives $34.3 million; the balance sheet shows $34.4 million. Source
  • Capital spending split maintenance and growth: Capital expenditures were $8.0 million, of which $5.1 million was discretionary. About $1.9 million of discretionary spending was customer-funded. Source
  • Credit sale proceeds expected second half: A four-year agreement to monetize Section 45Z and small producer credits is expected to bring $22 million of gross proceeds in the second half of 2026. Source
  • Returns framework includes buybacks and dividend: The documents describe a returns framework balancing reinvestment with share repurchases under the existing authorization and a quarterly cash dividend. Dividends paid were $3.1 million in the six months. Source

Strategy and customer funding

  • Customer-funded Batesville capacity expansion: A customer agreed to invest $25 million in 2026 and up to $17 million in 2027 in Batesville, supporting capacity expected to come online in early fiscal 2028. Source
  • Capital-lite co-investment model: Management said the Batesville model is capital-lite, with customers co-investing in new capacity and capabilities, aimed at accelerating growth in core contract manufacturing markets. Source
  • Strategy spans growth, operations, returns: The strategy combines organic and inorganic growth in Chemicals and Biofuels, operational discipline in plant optimization, procurement and automation, and a returns-focused capital allocation framework. Source
  • Domestic production cited for reshoring: Management said the 100% domestic production footprint and vertical integration position the business for reshoring-related demand. Source

Coming up, as management said on 10 August 2026

  • Section 45Z proceeds in Q3 and Q4: About $3 million of credit proceeds is expected in the third quarter and $19 million in the fourth quarter. Source
  • Batesville capacity due in 2028: Customer-funded incremental production capacity is expected to come online in early fiscal 2028. Source

Figures management reported

FigureReported
Chemicals capacity utilization Source65%
Biofuels capacity utilization Source56%
Biofuel production volume Source8.4 million gallons
Total production growth, year over year Source26%
Chemicals production growth, year over year Source34%
Biofuels production growth, year over year Source21%
Total volume growth Source40.4%
Chemicals production capacity change, last twelve months Source+12%

Risks management discussed

  • External: Elevated soybean oil and other feedstock costs may continue to be a near-term headwind on Biofuels gross profit per gallon. Source
  • Financial: Gross profit also includes unrealized derivative gains, which the company excludes from its Adjusted EBITDA guidance. Source
  • Operational: A biodiesel plant outage of more than three weeks reduced output during the quarter. Source
  • Financial: Working capital for new program activity and growth capital spending partly offset the cash build in the quarter. Source

Earlier plans management reported on

  • On track: Management said it remains on pace for positive full-year 2026 Adjusted EBITDA, as stated before. Source
  • Met: The first-quarter release expected the derivative loss to be offset on sale of physical positions. Management says the second quarter offset it. Source
  • Not stated: Management reiterated that sales volumes are expected to improve in the second half of 2026 given regulatory clarity. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.